# PET-MRI in Diagnosing Patients With Colon or Rectal Cancer

> **NCT01807117** · NA · COMPLETED · sponsor: **Case Comprehensive Cancer Center** · enrollment: 15 (actual)

## Conditions studied

- Recurrent Colon Cancer
- Recurrent Rectal Cancer
- Stage IIA Colon Cancer
- Stage IIA Rectal Cancer
- Stage IIB Colon Cancer
- Stage IIB Rectal Cancer
- Stage IIC Colon Cancer
- Stage IIC Rectal Cancer
- Stage IIIA Colon Cancer
- Stage IIIA Rectal Cancer
- Stage IIIB Colon Cancer
- Stage IIIB Rectal Cancer
- Stage IIIC Colon Cancer
- Stage IIIC Rectal Cancer
- Stage IVA Colon Cancer
- Stage IVA Rectal Cancer
- Stage IVB Colon Cancer
- Stage IVB Rectal Cancer

## Interventions

- **PROCEDURE:** positron emission tomography
- **PROCEDURE:** computed tomography
- **PROCEDURE:** magnetic resonance imaging
- **RADIATION:** fludeoxyglucose F 18

## Key facts

- **NCT ID:** NCT01807117
- **Lead sponsor:** Case Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04
- **Primary completion:** 2014-03-05
- **Final completion:** 2014-03-05
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2021-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01807117

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01807117, "PET-MRI in Diagnosing Patients With Colon or Rectal Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01807117. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*